Eiichi Ogawa

The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

Eiichi Ogawa, Norihiro Furusyo, Kazuhiro Toyoda et al. · Antiviral Research · 2009 · 132 citations

Medicine, Internal Medicine, Radiology +17

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara et al. · Journal of Hepatology · 2012 · 129 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West

Hansen Dang, Yee Hui Yeo, Satoshi Yasuda et al. · Hepatology · 2019 · 115 citations

Pharmacy, Oncology, Hepatitis Pharmacotherapy +16

Short‐term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct‐acting anti‐viral treatment

Eiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura et al. · Alimentary Pharmacology & Therapeutics · 2017 · 111 citations · Full text

Medicine, Infectious Diseases, Hepatitis Pharmacotherapy +11

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

Yao‐Chun Hsu, Grace Lai‐Hung Wong, Chien‐Hung Chen et al. · The American Journal of Gastroenterology · 2019 · 101 citations

Pharmacy, Oncology, Pharmacotherapy +16